Inventions from new Senior Members are making mining safer and greener, advancing treatments for cancer, and improving healthcare through better cameras and visualization.

More than 1.5B people live with chronic pain worldwide, the most common cause of long-term disability in the US, and several BIO5 researchers are addressing the issue tackling the opioid epidemic using basic science and clinical approaches.

The National Academy of Inventors has named 61 academic inventors to the 2021 class of NAI Senior Members, including Drs. Meredith Hay and May Khanna.

In 2016 the trio came together with the aim to cure cancer through the company they created and call Reglagene. They built a technology to fight cancer that targets genes that become resistant to other therapies.

Recognizing the numerous researchers and startups that attributed to The University of Arizona's record setting year

Research conducted at the University of Arizona is discovering the mechanisms that lead to stunted brain growth in babies born with pontocerebellar hypoplasia type Ib

A new grant will allow a team of researchers, including 3 BIO5 Researchers, to test new drug candidates for idiopathic pulmonary fibrosis

UA Venture Capital Fund LLC invests in 3 startups, 2 of which were founded by BIO5 Members

The I-Squared event included a showcase of several of the top startups, inventions and inventors from across the UA. One of which was Regulonix, a startup aimed at creating non-opioid drugs for chronic pain, invented by Dr. Rajesh Khanna, BIO5 member, Dr.

Lindsey Chew, a University of Arizona neuroscience and cognitive science senior and a 2014 Flinn Foundation Scholar, will represent Arizona at the 22nd annual Posters on the Hill in Washington D.C. Chew works in the lab of Rajesh Khanna, a BIO5 member.

One example is UA drug startup Regulonix, which is developing a new class of non-opioid painkillers. Regulonix was co-founded by BIO5 member Rajesh Khanna, May Khanna, assistant professor of pharmacology and Rajesh’s spouse; and BIO5's Vijay Gokhale, Ph.D

Researchers in the UA College of Medicine have invented a new class of non-opioid compounds to treat pain. The UA has licensed the compounds to startup Regulonix, co-founded by Vijay Gokhale a research scientist at the BIO5 Institute.